FABP5 and psoriasis: Other studies revealed that FABP5 may represent mediators of and biomarkers for metabolic and cardiovascular disease in type 2 diabetes mellitus, thus it could play an important role and contribute to the development of cardiometabolic comorbidities in psoriasis [15, 16].